首站-论文投稿智能助手
典型文献
Efficacy of Wumei Baijiang prescription(乌梅败酱方)on regulatory T cells/helper T cells Immune balance in mice with ulcerative colitis
文献摘要:
OBJECTIVE:To observe the therapeutic effect of Wumei Baijiang prescription(乌梅败酱方),empirical prescription of Lu Zhizheng,on experimental ulcerative colitis(UC)mice,and to investigate the mechanism of the pres-cription in UC from the perspective of the immune bal-ance of regulatory T cells(Treg)and helper T cells(Th17).METHODS:Sixty C57BL/6 mice were randomly divided into 6 groups:normal group,model group,Chinese medicine group(high,medium and low dose group of Wumei Baijiang prescription)and control group(mesalazine sustained-release granules).Except for the normal group,the other groups used 2.5%dextran sulfate sodium to induce UC mice model.At the end of the model,the Chinese medicine group was given high,medium and low dose administration of Wumei Baijiang prescription,the control group was given slow-release granules of mesalazine,and the model group was given equal volume saline for 10 d.The changes of food intake,body weight,disease activity index(DAI)score,length of large intestine and histopathology were observed.The number of Treg,Th17,CD4+,CD8+cells in spleen was detected by flow cytometry.The expression of tumor necrosis factor-α(TNF-α),interleukin-10(IL-10)and C-reactive protein(CRP)in serum was detected by enzyme-linked immunosorbent assay.RESULTS:The middle and high-dose groups of Wumei Baijiang prescription were superior to the model group in terms of increasing food intake and body weight of colitis mice,restoring colon morphology,improving pathological damage,and reducing DAI(P<0.05).There was no statistical difference with the mesalazine group(P>0.05).Compared with the model group,the spleen Treg and CD4+of the mice in the high and middle dose groups of Wumei Baijiang prescription were higher,while Th17 and CD8+were lower(P<0.05),and there was no statistical difference compared with the mesalazine group(P>0.05).In addition,compared with the model group,the serum levels of TNF-α and CRP in mice with high and middle doses of Wumei Baijiang prescription and mesalazine group were lower(P<0.05),and IL-10 content was higher(P<0.05).CONCLUSIONS:Wumei Baijiang prescription can improve the general conditions of colitis mice,such as diarrhea,hematochezia,weight loss,and mucosal damage.The mechanism may be related to the regulation of Treg/Th17 immune balance.
文献关键词:
作者姓名:
SU Xiaolan;ZHANG Tao;GUO Song;WANG Xin;CHEN Lin;WEI Wei
作者机构:
the Gastroenterology department,Wangjing Hospital of China Academy of Chinese Medicinal Sciences,Beijing 100102,China;TCM diagnosis and treatment Functional Gastroenteropathy Beijing Key Laboratory,Beijing 100102,China
引用格式:
[1]SU Xiaolan;ZHANG Tao;GUO Song;WANG Xin;CHEN Lin;WEI Wei-.Efficacy of Wumei Baijiang prescription(乌梅败酱方)on regulatory T cells/helper T cells Immune balance in mice with ulcerative colitis)[J].中医杂志(英文版),2022(01):30-38
A类:
Wumei,Baijiang,Zhizheng,cription,mesalazine,CD8+cells,CD4+of,CD8+were,hematochezia
B类:
Efficacy,prescription,乌梅,regulatory,helper,Immune,balance,mice,ulcerative,colitis,OBJECTIVE,To,therapeutic,effect,empirical,Lu,experimental,UC,investigate,mechanism,from,perspective,immune,Treg,Th17,METHODS,Sixty,C57BL,randomly,divided,into,groups,normal,model,Chinese,medicine,medium,control,sustained,release,granules,Except,other,used,dextran,sulfate,sodium,induce,At,end,was,given,administration,slow,equal,volume,saline,changes,food,intake,body,weight,disease,activity,DAI,score,length,large,intestine,histopathology,observed,number,spleen,detected,by,flow,cytometry,expression,tumor,necrosis,interleukin,reactive,protein,serum,enzyme,linked,immunosorbent,assay,RESULTS,middle,superior,terms,increasing,restoring,colon,morphology,improving,pathological,damage,reducing,There,statistical,difference,Compared,higher,while,lower,there,compared,In,addition,levels,doses,content,CONCLUSIONS,can,improve,general,conditions,such,diarrhea,loss,mucosal,may,related,regulation
AB值:
0.370339
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Assessment of traditional Chinese medicine pattern in a bleomycin-induced pulmonary fibrosis mouse model:A pilot study
Xiaofeng Gu;Wan Wei;Zhaoheng Liu;Fang Cao;Zhisong Wu;Jie Xie;Tianfang Wang;Yang Jiao-Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,310003,China;Department of Geriatrics,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China;School of Life Sciences,Beijing University of Chinese Medicine,Beijing,102488,China;Department of Intensive Cae Unit.Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China;School of Postgraduate,Beijing University of Chinese Medicine,Beijing,100029,China;School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing,102488,China;Department of Respiratory,Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,100078,China
Therapeutic effects of the extract of Sancao Formula,a Chinese herbal compound,on imiquimod-induced psoriasis via cysteine-rich protein 61
Wan-jun Guo;Yi Wang;Yu Deng;Lin-yan Cheng;Xin Liu;Ruo-fan Xi;Sheng-jie Zhu;Xin-yi Feng;Liang Hua;Kan Ze;Jian-yong Zhu;Dong-jie Guo;Fu-lun Li-Department of Dermatology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China;School of Medicine,Chengdu University,Chengdu 610106,Sichuan Province,China;Institute of Cancer Biology and Drug Discovery,Chengdu University,Chengdu 610106,Sichuan Province,China;Clinical Laboratory Medicine Center,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。